SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report: July 12, 2002
(Date of earliest event reported:)
Moore Medical Corp.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-8903 22-1897821
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission File (I.R.S. Employer
of incorporation) Number) Identification No.)
389 John Downey Drive P.O. Box 1500, New Britain, CT 06050
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(860) 826-3600
--------------------------------------------------------------------------------
Registrant's telephone number, including area code
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
ITEM 5. OTHER EVENTS
------------
A copy of Moore Medical Corp.'s press release, dated July 12, 2002,
is attached hereto and also incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
------------------------------------------------------------------
(c) Exhibits: The following documents are filed as exhibits to
this report:
99.1 Press Release of Moore Medical Corp., dated
July 12, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Moore Medical Corp.
Date: July 12, 2002 /s/ Linda M. Autore
---------------------------------------
Linda M. Autore
President and Chief Executive Officer
EXHIBIT INDEX
99.1 Press Release of Moore Medical, dated July 12, 2002.